Selected Reading
- Castelli WP: Epidemiology of coronary heart disease: The Framingham Study. Am J Med 76(2A):4, 1984
- Dalen JE, Dalton WS: Does lowering cholesterol cause cancer? (commentary) JAMA 275:67, 1996
- Frick MH et al: Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317:1237, 1987
- Gould AL et al: Cholesterol reduction yields clinical benefit: A new look at old data. Circulation 91:2274, 1995
- Kagan A et al: Serum cholesterol and mortality in a Japanese-American population: The Honolulu Heart Program. Am J Epidemiol 114:11, 1981
- Keys A (ed). Coronary heart disease in seven countries. American Heart Association Monograph 29. Circulation 41 (Suppl 1):1, 1970
- LaRosa JC: Cholesterol agonistics. Ann Intern Med 124:505, 1996
- Law MR, Thompson SG, Wald N J. Assessing possible hazards of reducing serum cholesterol. BMJ 308:373, 1994
- Law MR, Wald N J, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 308:367, 1994
- Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease; II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251:351–74, 1984
- National Cholesterol Education Program: Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 89:1329–1445, 1994
- Newman TB, Hulley SB: Carcinogenicity of lipid-lowering drugs. JAMA 275:55, 1996
- Sacks FM et al: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335:1001, 1996
- Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383, 1994
- Scandinavian Simvastatin Survival Study Group. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet 345:1274, 1995
- Shepherd J et al, for the West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301, 1995
- Thompson GR, Hollyer J, Water DD: Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease. Curr Opin Lipidol 6:386, 1995